MeiraGTx Holdings (MGTX) Enterprise Value (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -344.25% |
| Sep 30, 2025 | 53.86% |
| Jun 30, 2025 | 51.65% |
| Mar 31, 2025 | 35.83% |
| Dec 31, 2024 | 17.09% |
| Sep 30, 2024 | -23.76% |
| Jun 30, 2024 | 16.00% |
| Mar 31, 2024 | 7.95% |
| Dec 31, 2023 | -102.86% |
| Sep 30, 2023 | 30.58% |
| Jun 30, 2023 | -34.88% |
| Mar 31, 2023 | 40.46% |
| Dec 31, 2022 | -0.71% |
| Sep 30, 2022 | -59.08% |
| Jun 30, 2022 | 36.63% |
| Mar 31, 2022 | 17.37% |
| Dec 31, 2021 | 4.13% |
| Sep 30, 2021 | 16.76% |
| Jun 30, 2021 | 13.47% |
| Mar 31, 2021 | 4.83% |
| Dec 31, 2020 | -16.67% |
| Sep 30, 2020 | 7.82% |
| Jun 30, 2020 | 7.58% |
| Mar 31, 2020 | 7.24% |
| Dec 31, 2019 | 10.35% |
| Sep 30, 2019 | -24.00% |
| Jun 30, 2019 | 10.12% |
| Mar 31, 2019 | -233.41% |
| Dec 31, 2018 | 23.09% |
| Sep 30, 2018 | 13.21% |
| Jun 30, 2018 | -214.60% |
| Mar 31, 2018 | -274.54% |
| Dec 31, 2017 | -59.95% |
| Sep 30, 2017 | -1.71% |